The reported issues involve the following syncardia temporary total artificial heart (tah-t) system components and are reported under two separate medical device reports: primary freedom driver s/n (b)(4) (mfr report # 3003761017-2016-00259 and freedom onboard battery s/n (b)(4) (mfr report # 3003761017-2016-00260).The customer reported that the patient reported that the freedom onboard battery would not charge beyond the second of five indicator lights.The customer also reported that the patient's onboard battery was exchanged.There was no reported patient impact.This alleged failure mode poses a low risk to the patient because although the freedom onboard battery has a low capacity, it did not prevent the freedom driver from performing its life-sustaining functions.In addition, patients are provided with several onboard batteries, and the freedom driver has a redundant power source of external wall power.The freedom onboard battery will be returned to syncardia for evaluation.The results of the investigation will be provided in a follow-up mdr.
|
The reported issues involve the following syncardia temporary total artificial heart (tah-t) system components and are reported under two separate medical device reports: primary freedom driver s/n (b)(4) (mfr report # 3003761017-2016-00259 and freedom onboard battery s/n (b)(4) (mfr report # 3003761017-2016-00260).The customer reported that the patient reported that the freedom onboard battery would not charge beyond the second of five indicator lights.The customer also reported that the patient's onboard battery was exchanged.There was no reported patient impact.The onboard battery was returned to syncardia for evaluation.Visual inspection of the onboard battery revealed no abnormalities.The onboard battery was connected to battery evaluation software, and review of the smbus (system management bus) data revealed no permanent faults and no anomalous values.The displayed relative state of charge was consistent with the displayed fuel gauge leds.There was no indication that the onboard battery exhibited an incorrect gas gauge indication for the smbus displayed state of charge.The onboard battery was tested and passed all testing, which included gas gauge tests in fully charged, fully discharged and 70 percent states of charge.The onboard battery performed as intended, and there was no evidence of a malfunction.The onboard battery was returned to clinical use.The reported issue posed a low risk to the patient because it would not prevent the patient's freedom driver from performing its life-sustaining functions.In addition, patients are provided with several onboard batteries, and the freedom driver has a redundant power source of external wall power.This issue will continue to be monitored and trended as part of the customer experience process.Syncardia has completed its evaluation of this complaint and is closing this file.
|